MyFinsight
Home
Blog
About
Back
Income Statement
Acumen Pharmaceuticals, Inc. (ABOS)
Acumen Pharmaceuticals, Inc. (ABOS)
source: myfinsight.com
Comprehensive loss
-$32,752K
(20.00%↑ Y/Y)
Net loss
-$32,718K
(20.10%↑ Y/Y)
Unrealized (gain) loss on
marketable securities
-$34K
(-525.00%↓ Y/Y)
Loss from operations
-$32,556K
(22.02%↑ Y/Y)
Total other (expense)
income
-$162K
(-120.25%↓ Y/Y)
Interest income
$1,111K
(-44.86%↓ Y/Y)
Total operating
expenses
$32,556K
(-22.02%↓ Y/Y)
Interest expense
$1,094K
(4.59%↑ Y/Y)
Change in fair value of
embedded derivatives
-$160K
(-300.00%↓ Y/Y)
Other expense, net
-$19K
(85.27%↑ Y/Y)
Research and development
$27,809K
(-25.09%↓ Y/Y)
General and
administrative
$4,747K
(2.64%↑ Y/Y)
Back